Steris (STE) is a Health Care Equipment company. STERIS sells infection-prevention consumables, capital equipment, and services to hospitals, plus contract sterilization for device and drug makers. Continuing operations report as Healthcare, Applied Sterilization Technologies, and Life Sciences. It was founded in 1985, is headquartered in Dublin, Ireland and employs about 17,937 people.

How does Steris make money?

As of 2026-Q2, Steris's revenue breaks down across Service (51%), Product (49%). See the revenue-by-segment chart for the full mix.

How has Steris's revenue and profitability trended?

Track Steris's quarterly and annual revenue, gross and net margins, and EPS in the interactive charts on this page. Data last updated August 26, 2026.

Who are Steris's main competitors?

Sterling groups Steris in the Healthcare sector, alongside Abbott Laboratories (ABT), Baxter International (BAX), Becton Dickinson (BDX), Boston Scientific (BSX), Edwards Lifesciences (EW) and GE HealthCare (GEHC).

If I'm investing in Steris, what similar companies should I consider?

If you are researching Steris, also look at Abbott Laboratories (ABT), Baxter International (BAX) and Becton Dickinson (BDX). You can compare all of them side by side or browse the full Healthcare sector on Sterling.